Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

CTMXCTMX
6 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in CYTOMX THERAPEUTICS INC.

GOLDMAN SACHS GROUP INC holds 2M shares of CTMX (CYTOMX THERAPEUTICS INC.), worth $7.5M as of 2026-Q2. The position was increased (+37.3% shares). CTMX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$7.5M

Current Shares

2M

Total Value Change

+$7.5M

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2M
+37.3%
$7.5M0.0%$3.75
36
2026-Q1
Decreased
1.5M
-40.7%
$6.9M0.0%$4.81
0
2025-Q4
Increased
2.5M
+449.6%
$10.5M0.0%$4.16
45
2025-Q3
Increased
447,753
+2950.5%
$1.4M0.0%$3.23
41
2025-Q2
Decreased
14,678
-76.2%
$33,3190.0%$2.25
0
2025-Q1
New
61,719
-
$39,2410.0%$0.63
31

Other major holders of CTMX: FMR LLC, BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used